3-Amino-Substituted Analogues of Fusidic Acid as Membrane-Active Antibacterial Compounds.
Elena V SalimovaOleg S MozgovojSvetlana S EfimovaOlga S OstroumovaLyudmila V ParfenovaPublished in: Membranes (2023)
Fusidic acid (FA) is an antibiotic with high activity against Staphylococcus aureus ; it has been used in clinical practice since the 1960s. However, the narrow antimicrobial spectrum of FA limits its application in the treatment of bacterial infections. In this regard, this work aims both at the study of the antimicrobial effect of a number of FA amines and at the identification of their potential biological targets. In this way, FA analogues containing aliphatic and aromatic amino groups and biogenic polyamine, spermine and spermidine, moieties at the C-3 atom, were synthesized (20 examples). Pyrazinecarboxamide-substituted analogues exhibit a high antibacterial activity against S. aureus (MRSA) with MIC ≤ 0.25 μg/mL. Spermine and spermidine derivatives, along with activity against S. aureus , also inhibit the growth and reproduction of Gram-negative bacteria Escherichia coli , Acinetobacter baumannii , and Pseudomonas aeruginosa , and have a high fungicidal effect against Candida albicans and Cryptococcus neoformans . The study of the membrane activity demonstrated that the spermidine- and spermine-containing compounds are able to immerse into membranes and disorder the lipidsleading to a detergent effect. Moreover, spermine-based compounds are also able to form ion-permeable pores in the lipid bilayers mimicking the bacterial membranes. Using molecular docking, inhibition of the protein synthesis elongation factor EF-G was proposed, and polyamine substituents were shown to make the greatest contribution to the stability of the complexes of fusidic acid derivatives with biological targets. This suggests that the antibacterial effect of the obtained compounds may be associated with both membrane activity and inhibition of the elongation factor EF-G.
Keyphrases
- molecular docking
- staphylococcus aureus
- pseudomonas aeruginosa
- biofilm formation
- acinetobacter baumannii
- molecular dynamics simulations
- candida albicans
- escherichia coli
- clinical practice
- multidrug resistant
- drug resistant
- structure activity relationship
- cystic fibrosis
- molecular dynamics
- silver nanoparticles
- methicillin resistant staphylococcus aureus